This is a synthetic peptide designed for use in combination with anti-THRA antibody (Catalog #: ARP34780_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
THRA
(Thyroid Hormone Receptor, alpha (THRA))
Hintergrund
The THRA gene encodes a protein that is a nuclear hormone receptor for triiodothyronine. It is one of the several receptors for thyroid hormone, and has been shown to mediate the biological activities of thyroid hormone. Knockout studies in mice suggest that the different receptors, while having certain extent of redundancy, may mediate different functions of thyroid hormone.
Protein Interaction Partner: GTF2B,BTG1,CDK7,MED21,NCOA1,PCSK2,AKAP13,BTG1,CCND1,CDK7,COPS2,CREB1,CREBBP,CUL1,ESR1,FUS,GTF2B,HDAC2,MED1,MED21,MEF2A,NCOA1,NCOA6,NCOR1,NCOR2,NR2F1,NSD1,OASL,PML,POU2F1,RGN,RXRA,RXRB,RXRG,SLC16A2,SRC,TDG,TRIM24,YWHAH,AKAP13,CCND1,CDK8,COPS2,DAP3,EP300,FUS,HDAC3,HR,Hdac2,ITGB3BP,MED1,MED12,MED16,MED21,MED24,MED6,MEF2A,NCOA6,NCOR1,NR0B2,NRIP1,Nr0b2,Nsd1,PARP1,POU2F1,RXRA,TDG,TRIM24,TRIP11,UBC,YWHAQ,alien